Effect of quercetin on the genotoxic potential of cisplatin

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Cancer

• Publication date

  1996-05-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/(SICI)1097-0215(19960503)66:3<404::AID-IJC23>3.0.CO;2-9PMID 8621265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites

  2004cited by this paper
• Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.

  1996cited by this paper
• Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

  1994cited by this paper
• Recommendations for the performance of UDS tests in vitro and in vivo.

  1994cited by this paper
• Induction of apoptosis by quercetin: involvement of heat shock protein.

  1994cited by this paper
• Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468.

  1994cited by this paper
• Mode of binding of quercetin to DNA.

  1994cited by this paper
• Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.

  1994cited by this paper
• Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

  1993cited by this paper
• Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II).

  1993cited by this paper
• Mutagenic activity of some platinum and palladium complexes.

  1993cited by this paper
• Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis‐diamminedichloroplatinum(II)

  1993cited by this paper
• Is Quercetin Carcinogenic?

  1992cited by this paper
• Oxygen species and the genotoxicity of quercetin.

  1992cited by this paper
• Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum(II)

  1992cited by this paper
• Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

  1991cited by this paper
• Bacterial mutagenesis and hepatocyte unscheduled DNA synthesis induced by chrysoidine azo-dye components.

  1990cited by this paper
• Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth.

  1990cited by this paper
• Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.

  1990cited by this paper
• Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.

  1990cited by this paper
• The effect of quercetin on cell cycle progression and growth of human gastric cancer cells

  1990cited by this paper
• Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids.

  1990cited by this paper
• Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetin

  1990cited by this paper
• Cisplatin/carboplatin cross-resistance in ovarian cancer.

  1989cited by this paper
• Mutagenicity of cisplatin and carboplatin used alone and in combination with four other anticancer drugs.

  1989cited by this paper
• Modification of in vivo heterocyclic amine genotoxicity by dietary flavonoids.

  1989cited by this paper
• Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases.

  1988cited by this paper
• Flavone mutagenicity in salmonella typhimurium: Dependence on the PKM101 plasmid and excision‐repair deficiency

  1988cited by this paper
• Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.

  1988cited by this paper
• Enhancement of the antiproliferative effect of cis‐diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C

  1988cited by this paper
• Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases

  1988cited by this paper
• Enhancement of the mutagenicity of 2-acetylaminofluorene by flavonoids and the structural requirements.

  1987cited by this paper
• Studies on mutagenesis and repair induced by platinum analogs.

  1986cited by this paper
• A nonparametric approach to the statistical analysis of mutagenicity data.

  1985cited by this paper
• Revised methods for the Salmonella mutagenicity test.

  1983cited by this paper
• Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin.

  1983cited by this paper
• Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids.

  1983cited by this paper
• Acute bracken poisoning in homogastric and ruminant animals

  1982cited by this paper
• Mutagenicity of platinum coordination complexes in Salmonella typhimurium.

  1980cited by this paper
• A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds.

  1980cited by this paper
• Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat.

  1979cited by this paper
• Platinum(II) complexes generate frame-shift mutations in test strains of Salmonella typhimurium.

  1979cited by this paper
• [4] Isolation and use of liver cells

  1978cited by this paper
• Isolation and use of liver cells.

  1978cited by this paper
• HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS

  1969cited by this paper
• A Multiple Comparison Procedure for Comparing Several Treatments with a Control

  1955cited by this paper

• The genotoxic properties of leaf extracts from three common Congolese medicinal plants, Cogniauxia Podolaena Baill. (1839), Dissotis Rotundifolia (Sm.) Triana (1872) and Emilia Coccinea G. Don (1839) using the Ames test, the in vitro micronucleus test and

  2026cites this paper
• Phyto-cytogenotoxic potential assessment of two medicinal plants: Davilla nitida (Vahl) Kubitzki and Davilla elliptica (A. St.-Hill) (Dilleniaceae)

  2024cites this paper
• QUERCETIN AS AN IMPORTANT NUTRACEUTICAL AND MEDICINAL AGENT

  2020cites this paper
• Treating the pH gradient inversion

  2020cites this paper
• Effect of cisplatin on chromosomes of male mice (Mus musculus)

  2018cites this paper
• GENOTOXICITY EVALUATION OF PEO-PPO BASED STAR BLOCK COPOLYMER T1107 AND MICELLE ENCAPSULATED ANTIOXIDANTS BY CYTOKINESIS-BLOCK MICRONUCLEUS (CBMN) ASSAY

  2017cites this paper
• Antioxidant, Antiinflammatory, and Antifibrotic Properties of Quercetin in the Liver

  2017cites this paper
• Synthesis and membrane-protective properties of aminomethyl derivatives of quercetin at the C-8 position

  2017cites this paper
• Quantification of polyphenolic compounds and flavonoids in Achillea millefolium and Equisetum arvense.

  2016cites this paper
• Molecular and cellular pharmacology Anti-cancer activity and mutagenic potential of novel copper ( II ) quinolinone Schiff base complexes in hepatocarcinoma cells

  2016cites this paper
• Evaluation of a single-dose PIGRET assay for cisplatin in rats compared with the RBC Pig-a assay.

  2016cites this paper
• C2,N-dimethylbenzylamine cyclopalladated compounds: evaluation of cytotoxic, mutagenic and antitubercular activities

  2015cites this paper
• Possible Synergistic Effect and Antioxidant Properties of Chitosan Nanoparticles and Quercetin against Carbon Tetrachloride-Induce Hepatotoxicity in Rats

  2015cites this paper
• Tempol protects human lymphocytes from genotoxicity induced by cisplatin.

  2014cites this paper
• Measuring DNA damage and associated epigenetic changes genome-wide in cells following exposure to platinum analogue chemotherapeutic drugs

  2014cites this paper
• Carvedilol efficiently protects kidneys without affecting the antitumor efficacy of cisplatin in mice.

  2013cites this paper
• Positive and negative influence of the matrix architecture on antitumor immune surveillance

  2013cites this paper
• Elucidation of the molecular interaction between cisplatin and flavonol(s) and their effect on DNA binding.

  2013cites this paper
• Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells

  2012cites this paper
• Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells.

  2012cites this paper
• Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: protective effect of recombinant human erythropoietin.

  2012cites this paper
• Effects of organoselenium compound 2-(5-selenocyanato-pentyl)-benzo[de]isoquinoline 1,3-dione on cisplatin induced nephrotoxicity and genotoxicity: an investigation of the influence of the compound on oxidative stress and antioxidant enzyme system

  2012cites this paper
• Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.

  2011cites this paper
• Massive accumulation of gallic acid and unique occurrence of myricetin, quercetin, and kaempferol in preparing old oolong tea.

  2008cites this paper
• CANADIAN JOURNAL OF PURE AND APPLIED SCIENCES

  2008cites this paper
• Evaluation of the potential in vivo genotoxicity of quercetin.

  2008cites this paper
• A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.

  2007cites this paper
• Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution.

  2007cites this paper
• RETRACTED: In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines

  2007cites this paper
• In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.

  2007cites this paper
• Biological Flora of the British Isles: Pteridium aquilinum (L.) Kuhn

  2006cites this paper
• Oxidant/antioxidant properties of Croatian native propolis.

  2006cites this paper
• In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.

  2006cites this paper
• Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.

  2005cites this paper
• Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer

  2005cites this paper
• Flavonoids as enhancers of x-ray-induced cell damage in Updated Version

  2005cites this paper
• Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells.

  2003cites this paper
• Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma.

  2003cites this paper
• Comparison of methods for the hydrolysis of flavonoids and phenolic acids from onion and spinach for HPLC analysis

  2002cites this paper
• The identification and characterisation of quercetin metabolites in humans and rats

  2001cites this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cites this paper
• Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin

  1998cites this paper
• Determination of quercetin in human plasma by HPLC with spectrophotometric or electrochemical detection.

  1998cites this paper
• STUDIES ON THE CHROMOSOMES OF MURINE DALTON'S LYMPHOMA CELLS AND THE EFFECT OF CISPLATIN ON CHROMOSOMES OF THESE CELLS AND BONE MARROW CELLS IN VIVO

  1998cites this paper
• Vitamin C mediated protection on cisplatin induced mutagenicity in mice.

  1998cites this paper
• Exposure Data

  1997cites this paper
• Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.

  1997cites this paper
• Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.

  1997cites this paper